Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nestle Health Science SA

Division of Nestle SA
www.nestlehealthscience.com

Latest From Nestle Health Science SA

Health And Wellness Market News: Nestle Invests In Amazentis, CBD Launches, More

PepsiCo promotes Steven Williams to CEO of North American division; Nestle invests in Amazentis to create supplements with its natural bioactive that improves mitochondrial function; Anlit introduces probiotic chews for women; CBD topical pain relief from Omax; more news.

Aimmune Lays Foundations In Europe For Lead Peanut Allergy Therapeutic

With Aimmune’s AR101 oral immunotherapeutic nearing the market in the EU and US, the company sketches out its European business strategy after ARTEMIS meets its primary endpoint.

 

Immune Disorders Advertising, Marketing & Sales

US Rights Deal Will Make Proleukin Clinigen's Biggest Product

Clinigen's planned purchase of US rights to Proleukin will give it global ownership of the IL-2 drug.

Business Strategies Deals

Nestlé Grows Health Offering With Global Deal for Anti-Aging Supplement

In line with its nutrition, health and wellness strategy, Nestlé has bolstered its consumer health offering with ChromaDex’ innovative energy boosting supplement.

Deals Dietary Supplements
See All

Company Information

UsernamePublicRestriction

Register